OPTI PING
SBTX PINGY
SYME PONG |
OPTI SBTX
Between one of them that cant elaborate in an RNS or he would go to jail, and the other one trying to find an auditor after his car broke down - it gets even more comic by the day |
Apart from robbing everyone like. I mean, what else? |
The media 'finding hidden clues' in RNS's here since 2016
And this dude is still a CEO that can't write a fkn RNS?
Seriously?
If he can't communicate properly via RNS's , what's he doing there? |
40's soon folks |
once every 10 years anyway tbf. But still... |
Oh umm forgot. Accountability in those |
Fkg amazing how they can never fully elaborate in an RNS ain't it |
SO O Hara spoke to TW? Anything of note like numbers etc, will be in an RNS soon then? |
Fair play. They are nearly as big as that NDA distributor in Bulgaria re Velinoff |
Big marketing investment re above 5p. Nice way to ship sbtx dump cash across water at least |
ANyway, looking forward to OPTI confirming via RNS, that they agree with the forecast. it would be much better than some author sticking a note in for them from anywhere but here land |
Better known in some circles as the '3 B's Model' |
I think they had a look at sales of such products there last year. They also had a look at SlimShady performances and ran a model with 3 permutations and fair distribution mean calc. Base, Optimisitc, Pessimistic
Tbh, the pessimistic one was the best result |
I know a few smart dudes who know Morepen's financials very well you see. They had a look at SLimeShady performance from other outlets and just asking |
Finally, can i see what data the forecasts were based upon please
Thanks |
Why is OPTI not forecasting the revenues directly, via a UK RNS?
Off-shore forecasts attached seem a bit iffy |
Varun Suri, CEO of Dr Morepen commented: "We see the partnership between Dr. Morepen and OptiBiotix as an important one and have high regard for the success OptiBiotix enjoys globally because of the science and functionality of the ingredient and trust in their brand.
.........
Ummmm, shall believe everything he says in future |
So, OPTI agree with that forecast? |
"Based on Morepen's current forecasts, this agreement could contribute in the region of £6-7 million revenue per annum to OptiBiotix in the next four to five years.
.....
Let me guess
Year 1-3, zero, then morepen gets suspended? |
Well at least we can see what revenues are coming in from KAG and marry it up to Morepen books anyway |
This is being supported by a £1.5million+ marketing investment........
Who is accounting for it? |
Were they excited by the performance of Slimbiome in H&B and thought it worthy of a 1.5M marketing investment? |
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Hot Features
Premium
